Details
Stereochemistry | RACEMIC |
Molecular Formula | C12H17NO2 |
Molecular Weight | 207.2689 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(C)CC1=CC2=C(OCCO2)C=C1
InChI
InChIKey=UJKWLAZYSLJTKA-UHFFFAOYSA-N
InChI=1S/C12H17NO2/c1-9(13-2)7-10-3-4-11-12(8-10)15-6-5-14-11/h3-4,8-9,13H,5-7H2,1-2H3
Molecular Formula | C12H17NO2 |
Molecular Weight | 207.2689 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL313 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26233799 |
117.0 nM [EC50] | ||
Target ID: CHEMBL304 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26233799 |
325.0 nM [EC50] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:41:44 GMT 2023
by
admin
on
Sat Dec 16 10:41:44 GMT 2023
|
Record UNII |
UJ7UU2C6E6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-EDMA
Created by
admin on Sat Dec 16 10:41:44 GMT 2023 , Edited by admin on Sat Dec 16 10:41:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
133787-66-3
Created by
admin on Sat Dec 16 10:41:44 GMT 2023 , Edited by admin on Sat Dec 16 10:41:44 GMT 2023
|
PRIMARY | |||
|
24257269
Created by
admin on Sat Dec 16 10:41:44 GMT 2023 , Edited by admin on Sat Dec 16 10:41:44 GMT 2023
|
PRIMARY | |||
|
UJ7UU2C6E6
Created by
admin on Sat Dec 16 10:41:44 GMT 2023 , Edited by admin on Sat Dec 16 10:41:44 GMT 2023
|
PRIMARY | |||
|
DTXSID501027143
Created by
admin on Sat Dec 16 10:41:44 GMT 2023 , Edited by admin on Sat Dec 16 10:41:44 GMT 2023
|
PRIMARY | |||
|
EDMA
Created by
admin on Sat Dec 16 10:41:44 GMT 2023 , Edited by admin on Sat Dec 16 10:41:44 GMT 2023
|
PRIMARY | 3,4-Ethylenedioxy-N-methylamphetamine (EDMA) is an entactogen drug of the amphetamine class. It is an analogue of MDMA where the methylenedioxy ring has been replaced by an ethylenedioxy ring. EDMA was first synthesized by Alexander Shulgin.[1] In his book PiHKAL, the dosage is listed as 150?250 mg, and the duration listed as 3?5 hours. According to Shulgin, EDMA produces a bare threshold consisting of paresthesia, nystagmus, and hypnogogic imagery, with few to no other effects. |